- Home
- CGNX
CGNX
Cognex Corporation
as of 03-04-2026 12:08pm EST
$53.81
+$0.20
+0.37%
Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.
| Founded: | 1981 | Country: | United States |
| Employees: | N/A | City: | NATICK |
| Market Cap: | 6.0B | IPO Year: | 1994 |
| Target Price: | $55.08 | AVG Volume (30 days): | 2.8M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | Dividend Payout Frequency: | annual | |
| EPS: | 0.68 | EPS Growth: | 9.68 |
| 52 Week Low/High: | $22.67 - $59.88 | Next Earning Date: | 05-13-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 9.92% | Revenue Growth (next year): | 8.78% |
| P/E Ratio: | 78.82 | Index: | N/A |
| Free Cash Flow: | 236.8M | FCF Growth: | +76.64% |
AI-Powered CGNX Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 18 hours ago
AI Recommendation
hold
Model Accuracy: 72.44%
72.44%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Cognex Corporation (CGNX)
PARROTTE DIANNE M
Sell
Director
CGNX Mar 2, 2026
Avg Cost/Share
$54.00
Shares
44,000
Total Value
$2,376,000.00
Owned After
33,431
Gerst Carl
Sell
EVP, Global Sales and Products
CGNX Feb 23, 2026
Avg Cost/Share
$55.93
Shares
10,532
Total Value
$589,042.12
Owned After
0
SEC Form 4
Papadimitriou Angelos
Sell
Director
CGNX Feb 23, 2026
Avg Cost/Share
$55.58
Shares
4,150
Total Value
$230,658.66
Owned After
16,222
SEC Form 4
Kuechen Joerg
Sell
Head of Corporate M&A
CGNX Feb 20, 2026
Avg Cost/Share
$56.07
Shares
61,900
Total Value
$3,468,385.93
Owned After
0
Gerst Carl
Sell
EVP, Global Sales and Products
CGNX Feb 20, 2026
Avg Cost/Share
$55.99
Shares
3,804
Total Value
$212,979.49
Owned After
0
SEC Form 4
Willett Robert
Sell
Director
CGNX Feb 13, 2026
Avg Cost/Share
$59.50
Shares
2,148
Total Value
$127,808.36
Owned After
0
SEC Form 4
MACDONALD LAURA ANN
Sell
VP and PAO
CGNX Feb 12, 2026
Avg Cost/Share
$56.92
Shares
14,881
Total Value
$850,553.11
Owned After
2,212
Willett Robert
Sell
Director
CGNX Feb 12, 2026
Avg Cost/Share
$58.39
Shares
177,052
Total Value
$10,337,198.73
Owned After
0
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| PARROTTE DIANNE M | CGNX | Director | Mar 2, 2026 | Sell | $54.00 | 44,000 | $2,376,000.00 | 33,431 | |
| Gerst Carl | CGNX | EVP, Global Sales and Products | Feb 23, 2026 | Sell | $55.93 | 10,532 | $589,042.12 | 0 | |
| Papadimitriou Angelos | CGNX | Director | Feb 23, 2026 | Sell | $55.58 | 4,150 | $230,658.66 | 16,222 | |
| Kuechen Joerg | CGNX | Head of Corporate M&A | Feb 20, 2026 | Sell | $56.07 | 61,900 | $3,468,385.93 | 0 | |
| Gerst Carl | CGNX | EVP, Global Sales and Products | Feb 20, 2026 | Sell | $55.99 | 3,804 | $212,979.49 | 0 | |
| Willett Robert | CGNX | Director | Feb 13, 2026 | Sell | $59.50 | 2,148 | $127,808.36 | 0 | |
| MACDONALD LAURA ANN | CGNX | VP and PAO | Feb 12, 2026 | Sell | $56.92 | 14,881 | $850,553.11 | 2,212 | |
| Willett Robert | CGNX | Director | Feb 12, 2026 | Sell | $58.39 | 177,052 | $10,337,198.73 | 0 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K SELL Feb 11, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K SELLFeb 11, 2026 · 100% conf.
AI Prediction SELL
1D
-9.71%
$38.85
5D
-10.84%
$38.37
20D
-10.53%
$38.50
Price: $43.03 Prob +5D: 0% AUC: 1.000
0000851205-26-000009
cgnx-202602110000851205FALSE00008512052026-02-112026-02-11
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
February 11, 2026 Date of Report (date of earliest event reported)
Cognex Corporation (Exact name of registrant as specified in its charter)
Massachusetts (State or other jurisdiction of incorporation or organization) 001-34218 (Commission File Number) 04-2713778 (I.R.S. Employer Identification Number)
One Vision Drive Natick, Massachusetts 01760
(Address of principal executive offices and zip code)
(508) 650-3000
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol Name of each exchange on which registered
Common stock, par value $.002 per shareCGNXThe NASDAQ Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 - Results of Operations and Financial Condition On February 11, 2026, Cognex Corporation (the "Company") issued a news release to report its financial results for the quarter and year ended December 31, 2025. The release is furnished as Exhibit 99.1 hereto. The information in Item 2.02 of this Current Report on Form 8-K, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, regardless of any general incorporation language in such filing.
Item 8.01 - Other Events On February 11, 2026, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.085 per share. The dividend is payable on March 12, 2026, to all shareholders of record at the close of business on February 26, 2026.
Additionally, on February 11, 2026, the Company announced that its Board of Directors authorized the repurchase of an additional $500,000,000 of the Company’s common stock through open market purchases, privately negotiated transactions or otherwise in compliance with applicable securities laws. The Board also reauthorized the Company to establish Rule 10b5-1 trading plans. The Company may repurchase shares pursuant to its repurchase program depending upon a variety of factors, including, among other things, the impact of dilution from equity-based awards, stock price, share availability, and cash requirements.
Item 9.01 - Financial Statements and Exhibits (d) Exhibits
Exhibit No.Description 99.1News release, dated February 11, 2026, by Cognex Corporation with respect to financial results for the quarter and year ended December 31, 2025 (furnished herewith)
104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 11th day of February, 2026.
COGNEX CORPORATION
By: /s/ Dennis Fehr Name: Dennis Fehr Title: Senior Vice President of Finance and Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Oct 29, 2025
2025
Q3
Q3 2025 Earnings
8-KOct 29, 2025
0000851205-25-000061
cgnx-202510290000851205FALSE00008512052025-10-292025-10-29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
October 29, 2025 Date of Report (date of earliest event reported)
Cognex Corporation (Exact name of registrant as specified in its charter)
Massachusetts (State or other jurisdiction of incorporation or organization) 001-34218 (Commission File Number) 04-2713778 (I.R.S. Employer Identification Number)
One Vision Drive Natick, Massachusetts 01760
(Address of principal executive offices and zip code)
(508) 650-3000
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol Name of each exchange on which registered
Common stock, par value $.002 per shareCGNXThe NASDAQ Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 - Results of Operations and Financial Condition On October 29, 2025, Cognex Corporation (the "Company") issued a news release to report its financial results for the quarter ended September 28, 2025. The release is furnished as Exhibit 99.1 hereto. The information in Item 2.02 of this Current Report on Form 8-K, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, regardless of any general incorporation language in such filing.
Item 8.01 - Other Events On October 29, 2025, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.085 per share. The dividend is payable on November 28, 2025, to all shareholders of record at the close of business on November 13, 2025.
Item 9.01 - Financial Statements and Exhibits (d) Exhibits
Exhibit No.Description 99.1News release, dated October 29, 2025, by Cognex Corporation with respect to financial results for the quarter ended September 28, 2025 (furnished herewith)
104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 29th day of October, 2025.
COGNEX CORPORATION
By: /s/ Dennis Fehr Name: Dennis Fehr Title: Senior Vice President of Finance and Chief Financial Officer
2025 Q2 Q2 2025 Earnings
8-K Jul 30, 2025
2025
Q2
Q2 2025 Earnings
8-KJul 30, 2025
0000851205-25-000050
cgnx-202507300000851205FALSE00008512052025-07-302025-07-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
July 30, 2025 Date of Report (date of earliest event reported)
Cognex Corporation (Exact name of registrant as specified in its charter)
Massachusetts (State or other jurisdiction of incorporation or organization) 001-34218 (Commission File Number) 04-2713778 (I.R.S. Employer Identification Number)
One Vision Drive Natick, Massachusetts 01760-2059
(Address of principal executive offices and zip code)
(508) 650-3000
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol Name of each exchange on which registered
Common stock, par value $.002 per shareCGNXThe NASDAQ Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 - Results of Operations and Financial Condition On July 30, 2025, Cognex Corporation (the "Company") issued a news release to report its financial results for the quarter ended June 29, 2025. The release is furnished as Exhibit 99.1 hereto. The information in Item 2.02 of this Current Report on Form 8-K, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, regardless of any general incorporation language in such filing.
Item 8.01 - Other Events On July 30, 2025, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.08 per share. The dividend is payable on August 28, 2025, to all shareholders of record at the close of business on August 14, 2025.
Item 9.01 - Financial Statements and Exhibits (d) Exhibits
Exhibit No.Description 99.1News release, dated July 30, 2025, by Cognex Corporation with respect to financial results for the quarter ended June 29, 2025 (furnished herewith)
104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 30th day of July, 2025.
COGNEX CORPORATION
By: /s/ Dennis Fehr Name: Dennis Fehr Title: Senior Vice President of Finance and Chief Financial Officer
Latest Cognex Corporation News
CGNX Breaking Stock News: Dive into CGNX Ticker-Specific Updates for Smart Investing
Motley Fool
One Fund Bet $5 Million on Enovis Stock Last Quarter. Shares Surged 14% Post-Earnings
📈
AI Sentiment
Highly Positive
8/10
Compare CGNX vs Leading Stocks
See how CGNX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CGNX Cognex Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.